Creatinine at the evaluation of urinary 1-methyladenosine and pseudouridine excretion

Tohoku Journal of Experimental Medicine

Volumn 188, Issue 2, 1999, Pages 133-138

  Honda, Ichiyo ^a,c   Itoh, Kunihiko ^b   Mizugaki, Michinao ^b   Sasaki, Takeshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c National Hospital Organization Iwate Hospital   (Japan)

Author keywords

1 Methyladenosine; Creatinine excretion; Modified nucleosides; Pseudouridine

Indexed keywords

1 METHYLADENOSINE; 1-METHYLADENOSINE; ADENOSINE; CREATININE; DRUG DERIVATIVE; PSEUDOURIDINE;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; KIDNEY DISEASE; LABORATORY DIAGNOSIS; NEOPLASM; URINE; UROGENITAL TRACT DISEASE;

ADENOSINE; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE UROGENITAL DISEASES; HUMANS; KIDNEY DISEASES; MALE UROGENITAL DISEASES; NEOPLASMS; PSEUDOURIDINE;

EID: 0033143142     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.188.133     Document Type: Article

References (12)

1. Borek, E., Baliga, B.S., Gehrke, C.W., Kuo, K.C., Belman, S., Troll, W. & Waalkes, T.P. (1977) High turnover rate of transfer RNA in tumor tissue. Cancer Res., 37, 3362-3366.
2. Davis, G.E., Suits, R.D., Kuo, K.C., Gehrke, C.W., Waalkes, T.P. & Borek, E. (1977) High performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids. Clin. Chem., 23, 1427-1435.
3. Fishbein, A., Sharma, O.K., Selikoff, I.J. & Borek, E. (1983) Urinary excretion of modified nucleosides in patients with malignant mesothelioma. Cancer Res., 43, 2971-2974.
4. Gehrke, C.W., Kuo, K.C., Waalkes, T.P. & Borek, E. (1979) Patterns of urinary excretion of modified nucleosides. Cancer Res., 39, 1150-1153.
5. Heldman, D.A., Grever, M.R., Miser, J.S. & Trewyn, R.W. (1983) Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia. J. Natl. Cancer Inst., 71, 269-273.
6. Itoh, K., Mizugaki, M. & Ishida, N. (1988) Preparation of a monoclonal antibody specific for 1-methyladenosine and its application for the detection of elevated levels of 1-methyladenosine in urines from cancer patients. Jpn. J. Cancer Res. (Gann), 79, 1130-1138.
7. Itoh, K., Mizugaki, M. & Ishida, N. (1989) Detection of elevated amounts of urinary pseudouridine in cancer patients by use of a monoclonal antibody. Clin. Chim. Acta, 181, 305-316.
8. Itoh, K., Konno, T., Sasaki, T., Ishiwata, S., Ishida, N. & Mizugaki, M. (1992) Relationship of urinary pseudouridine and 1-methyladenosine to activity of leukemia and lymphoma. Clin. Chim. Acta, 206, 181-189.
9. Itoh, K., Aida, S., Ishiwata, S., Sasaki, S., Ishida, N. & Mizugaki, M. (1993) Urinary excretion patterns of modified nucleosides, pseudouridine and 1-methyladenosine, in healthy individuals. Clin. Chim. Acta, 217, 221-223.
10. Rasmuson, T., Bjork, G.R., Damber, L., Holm, S.E., Jacobson, L., Jappson, A., Littbrand, B., Stigbrand, T. & Westman, G. (1983) Evaluation of carcinoembrionic antigen, tissue polypeptide antigen, placental alkaline phosphatase, and modified nucleosides as biological markers in malignant lymphomas. Recent Res. Cancer Res., 84, 331-343.
11. Schoch, G. & Heller-Schoch, G. (1977) Molekularbiologie und klinische Bedeutung des Staffwechsels normales und modifizierter Nucleobasen. Helv. Pediatr. Acta, Suppl., 38, 7-171.
12. Waalkes, T.P., Gehrke, C.W., Zumwalt, R.W., Chang, S.Y., Lakings, D.B., Tormey, D.C., Ahmann, D.L. & Moertel, C.G. (1975) The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer. Cancer, 36, 390-398.